Health Care & Life Sciences » Biotechnology | Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S | Balance Sheet

Fiscal year is January-December. All values DKK Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
328,652.00
270,434.00
107,658.00
23,679.40
48,152.30
199,233
Total Accounts Receivable
15,170.00
8,953.00
15,851.00
16,270.40
27,337.60
45,447.60
Inventories
-
4,764.00
16,984.00
29,192.20
42,044.90
54,671.60
Other Current Assets
1,214.00
4,192.00
4,130.00
5,653.70
11,303.30
19,884.10
Total Current Assets
345,036.00
288,343.00
144,623.00
74,795.70
128,838.10
319,236.30
Net Property, Plant & Equipment
3,333.00
4,247.00
3,335.00
3,397.90
5,425.40
6,299.50
Intangible Assets
494.00
1,134.00
995.00
803.60
496.00
313.30
Total Assets
348,863.00
293,724.00
148,953.00
210,668.80
259,927.00
503,415.90
Accounts Payable
13,026.00
17,875.00
20,195.00
6,746.40
15,054.60
Income Tax Payable
-
470.00
-
-
-
Other Current Liabilities
56,795.00
22,131.00
39,099.00
34,655.60
51,829.10
Total Current Liabilities
69,821.00
40,476.00
59,294.00
41,402.00
66,883.70
Long-Term Debt
-
-
-
97,396.60
160,081.90
Deferred Taxes
-
-
-
131,671.50
125,167.50
Total Liabilities
69,821.00
40,476.00
59,294.00
138,798.60
226,965.60
Common Equity (Total)
279,042.00
253,248.00
89,659.00
71,870.20
32,961.30
Total Shareholders' Equity
279,042.00
253,248.00
89,659.00
71,870.20
32,961.30
Total Equity
279,042.00
253,248.00
89,659.00
71,870.20
32,961.30
Liabilities & Shareholders' Equity
348,863.00
293,724.00
148,953.00
210,668.80
259,927.00

About Veloxis Pharmaceuticals A/S

View Profile
Address
Amerika Plads 37
Copenhagen CR 2100
Denmark
Employees -
Website http://www.veloxis.com
Updated 07/08/2019
Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.